Alva Review-Courier -

By Linda a. Johnson
AP Medical Writer 

FDA OKs new Johnson & Johnson treatment for psoriasis

 


TRENTON, N.J. (AP) — U.S. regulators approved a new psoriasis drug from Johnson & Johnson Thursday, giving people with the itchy and painful condition another treatment option.

Johnson & Johnson said that in one patient study, about seven in 10 patients getting the drug, Tremfya, had clear or nearly clear skin after 24 weeks of treatment. That compares with about four in 10 patients receiving rival AbbVie's Humira, which treats several immune disorders and is the world's top selling drug.

Tremfya, which is injected every eight weeks, can cause infections and other serious side effects. Be...



For access to this article please sign in or subscribe.



 

Reader Comments(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020